Turn Therapeutics (TTRX) announces that its common stock is scheduled to commence trading, October 8, 2025, on the Nasdaq Capital Market under ticker symbol “TTRX.” The Company’s registration statement on Form S-1 was declared effective by the U.S. Securities and Exchange Commission September 30, 2025. Clear Street served as financial advisor to the company. Davis, Polk, and Wardwell acted as legal counsel.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks